"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","22/31","481/2914",1.87139160005057e-11,5.64480073430017e-09,3.47783931497167e-09,"TP53/EP300/MAPK3/ABL1/MAPK14/BRCA1/NR0B2/GSK3B/YAP1/CSNK2A1/CDK2/SMAD1/CDK5/CDK1/LEF1/CTNNB1/TCF7/JUN/KLF4/VDR/MAPK1/NR2C2AP",22
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","8/31","23/2914",2.72394304558071e-11,5.64480073430017e-09,3.47783931497167e-09,"MAPK3/CDK1/MAPK1/DUSP7/DUSP10/DUSP8/DUSP2/DUSP9",8
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","22/31","499/2914",4.012891517275e-11,5.64480073430017e-09,3.47783931497167e-09,"TP53/EP300/MAPK3/ABL1/MAPK14/BRCA1/NR0B2/GSK3B/YAP1/CSNK2A1/CDK2/SMAD1/CDK5/CDK1/LEF1/CTNNB1/TCF7/JUN/KLF4/VDR/MAPK1/NR2C2AP",22
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","7/31","34/2914",3.30786818457348e-08,3.48980093472502e-06,2.15011431997276e-06,"MAPK3/MAPK1/DUSP7/DUSP10/DUSP8/DUSP2/DUSP9",7
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","11/31","187/2914",1.55079331319605e-06,0.000121385107519901,7.47870330691332e-05,"TP53/HIF1A/STAT3/EP300/MAPK3/MAPK14/GSK3B/CDK2/JUN/ETS2/MAPK1",11
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","11/31","189/2914",1.72585460928769e-06,0.000121385107519901,7.47870330691332e-05,"TP53/HIF1A/STAT3/EP300/MAPK3/MAPK14/GSK3B/CDK2/JUN/ETS2/MAPK1",11
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","4/31","10/2914",2.10757020329644e-06,0.000127056375113014,7.8281178979582e-05,"MAPK3/MAPK14/JUN/MAPK1",4
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","7/31","62/2914",2.46461325476905e-06,0.000130008349189067,8.0099930779994e-05,"MAPK3/ABL1/GSK3B/YAP1/SMAD1/CDK1/MAPK1",7
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","5/31","24/2914",3.59040805419311e-06,0.000168350244318832,0.000103722899343356,"MAPK3/ABL1/YAP1/SMAD1/MAPK1",5
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","8/31","95/2914",4.03894087987202e-06,0.000170443305130599,0.000105012462876673,"TP53/EP300/MAPK14/BRCA1/CSNK2A1/CDK2/CDK5/CDK1",8
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","8/31","99/2914",5.52730220190693e-06,0.000212047411745884,0.000130645324772346,"TP53/STAT3/MAPK3/MAPK14/CDK2/JUN/ETS2/MAPK1",8
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","5/31","30/2914",1.15089287523e-05,0.000404730661122551,0.000249360122966501,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","6/31","53/2914",1.40973689950011e-05,0.000457622285837728,0.000281947379900022,"TP53/EP300/YAP1/LEF1/CTNNB1/TCF7",6
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","14/31","397/2914",1.77189598541521e-05,0.000534100075603728,0.000329066397291397,"STAT3/EP300/MAPK3/ABL1/MAPK14/GSK3B/CSNK2A1/CDK2/CDK5/LEF1/CTNNB1/JUN/KLF4/MAPK1",14
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","6/31","56/2914",1.94972968408474e-05,0.000548523951122508,0.000337953145241355,"TP53/MAPK14/BRCA1/CSNK2A1/CDK2/CDK5",6
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/31","19/2914",3.63776195781608e-05,0.00095945971637399,0.000591136318145112,"MAPK3/ABL1/YAP1/MAPK1",4
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","4/31","21/2914",5.53409393834856e-05,0.00137375743646064,0.00084639083762978,"MAPK3/MAPK14/MAPK1/DUSP7",4
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","4/31","22/2914",6.71371375631163e-05,0.0015739928917575,0.000969758653689458,"EP300/LEF1/CTNNB1/TCF7",4
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/31","44/2914",7.89724841409835e-05,0.00170210268814685,0.00104868885999569,"TP53/MAPK3/MAPK14/JUN/MAPK1",5
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/31","23/2914",8.06683738458221e-05,0.00170210268814685,0.00104868885999569,"TP53/MAPK3/ETS2/MAPK1",4
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/31","45/2914",8.8180502983625e-05,0.0017720082028138,0.00109175860836869,"STAT3/MAPK3/CDK2/JUN/MAPK1",5
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","4/31","24/2914",9.60839670041481e-05,0.00184306518526139,0.0011355377918672,"MAPK3/MAPK14/MAPK1/DUSP7",4
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","9/31","191/2914",0.0001054762739237,0.00193526033025223,0.00119234048783313,"TP53/EP300/MAPK3/ABL1/GSK3B/CSNK2A1/CDK2/CDK1/MAPK1",9
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","9/31","194/2914",0.00011914279181607,0.0020949274227659,0.00129071357800743,"TP53/EP300/MAPK14/BRCA1/CSNK2A1/CDK2/CDK5/CDK1/JUN",9
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","10/31","249/2914",0.000153134669754134,0.00251882085283084,0.00155188014629388,"TP53/EP300/MAPK3/ABL1/BRCA1/GSK3B/CSNK2A1/CDK2/CDK1/MAPK1",10
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/31","27/2914",0.000155188014629388,0.00251882085283084,0.00155188014629388,"STAT3/EP300/CDK2/LEF1",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","9/31","202/2914",0.000163099187422353,0.00254917989230492,0.0015705847677708,"MAPK3/CDK1/JUN/MAPK1/DUSP7/DUSP10/DUSP8/DUSP2/DUSP9",9
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/31","12/2914",0.000224909179750691,0.00338970263767114,0.00208844238339928,"MAPK3/MAPK1/DUSP7",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/31","30/2914",0.00023698020955126,0.00344847063553902,0.0021246501545975,"TP53/EP300/CDK2/CDK1",4
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","6/31","89/2914",0.000272782175887947,0.00383713594082379,0.00236411219102888,"STAT3/MAPK3/MAPK14/CDK5/MAPK1/DUSP7",6
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/31","32/2914",0.000306363374445317,0.0041704949682556,0.00256949926954137,"TP53/MAPK3/JUN/MAPK1",4
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","5/31","59/2914",0.000325320271615395,0.00429016108192802,0.00264322720687508,"TP53/MAPK3/CSNK2A1/JUN/MAPK1",5
"R-HSA-450294","R-HSA-450294","MAP kinase activation","5/31","60/2914",0.000352242042729768,0.00450442854642309,0.00277524033665878,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","8/31","177/2914",0.00037300888458997,0.00462969850873433,0.00285242088215859,"MAPK3/CDK1/MAPK1/DUSP7/DUSP10/DUSP8/DUSP2/DUSP9",8
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/31","15/2914",0.000455180097767371,0.00548817146450945,0.00338133786912904,"TP53/EP300/CDK1",3
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","5/31","64/2914",0.000477204687366538,0.00559389939079664,0.00344647829764722,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","4/31","37/2914",0.00054212207697846,0.00617664465240063,0.0038055156626165,"GSK3B/LEF1/CTNNB1/TCF7",4
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/31","16/2914",0.000556190750690104,0.00617664465240063,0.0038055156626165,"MAPK3/MAPK14/MAPK1",3
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","5/31","70/2914",0.000724148971211511,0.00783566322695533,0.00482765980807674,"STAT3/MAPK3/MAPK14/MAPK1/DUSP7",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","6/31","108/2914",0.000779164493143684,0.00822018540266587,0.00506456920543395,"EP300/GSK3B/CSNK2A1/LEF1/CTNNB1/TCF7",6
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/31","20/2914",0.00110002669449588,0.0113222259774942,0.00697577903826655,"MAPK3/CSNK2A1/MAPK1",3
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","5/31","78/2914",0.00118948521622983,0.0114082445738406,0.00702877627772172,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","5/31","78/2914",0.00118948521622983,0.0114082445738406,0.00702877627772172,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","5/31","78/2914",0.00118948521622983,0.0114082445738406,0.00702877627772172,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-525793","R-HSA-525793","Myogenesis","3/31","22/2914",0.00146472054219116,0.0133528128877658,0.00822685154222536,"ABL1/MAPK14/CTNNB1",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","5/31","83/2914",0.00157562558462072,0.0133528128877658,0.00822685154222536,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/31","49/2914",0.00159064336627284,0.0133528128877658,0.00822685154222536,"TP53/STAT3/MAPK3/MAPK1",4
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","4/31","49/2914",0.00159064336627284,0.0133528128877658,0.00822685154222536,"EP300/MAPK3/GSK3B/MAPK1",4
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","6/31","124/2914",0.00161263793399726,0.0133528128877658,0.00822685154222536,"TP53/HIF1A/EP300/BRCA1/SMAD1/CDK1",6
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","5/31","84/2914",0.00166281221439075,0.0133528128877658,0.00822685154222536,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","5/31","84/2914",0.00166281221439075,0.0133528128877658,0.00822685154222536,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/31","23/2914",0.00167232836744296,0.0133528128877658,0.00822685154222536,"TP53/EP300/JUN",3
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","7/31","171/2914",0.00167701204514594,0.0133528128877658,0.00822685154222536,"MAPK3/MAPK1/DUSP7/DUSP10/DUSP8/DUSP2/DUSP9",7
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","5/31","86/2914",0.00184782648223314,0.0136856495423234,0.0084319167796305,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","5/31","86/2914",0.00184782648223314,0.0136856495423234,0.0084319167796305,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","5/31","86/2914",0.00184782648223314,0.0136856495423234,0.0084319167796305,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/31","24/2914",0.00189750613893422,0.0136856495423234,0.0084319167796305,"STAT3/MAPK3/MAPK1",3
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","5/31","87/2914",0.0019458269491455,0.0136856495423234,0.0084319167796305,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","5/31","87/2914",0.0019458269491455,0.0136856495423234,0.0084319167796305,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","5/31","87/2914",0.0019458269491455,0.0136856495423234,0.0084319167796305,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/31","25/2914",0.0021407746316708,0.0148099490912308,0.00912461318417061,"MAPK3/ABL1/MAPK1",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","5/31","90/2914",0.00226284751848814,0.0151574865524126,0.00933873579058596,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","5/31","90/2914",0.00226284751848814,0.0151574865524126,0.00933873579058596,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","7/31","188/2914",0.00290055971904345,0.0191255656474427,0.011783523858614,"MAPK3/MAPK1/DUSP7/DUSP10/DUSP8/DUSP2/DUSP9",7
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/31","29/2914",0.00330446330118282,0.0208131867626739,0.0128232904225005,"TP53/EP300/JUN",3
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/31","29/2914",0.00330446330118282,0.0208131867626739,0.0128232904225005,"TP53/CDK2/CDK1",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/31","29/2914",0.00330446330118282,0.0208131867626739,0.0128232904225005,"TP53/CDK2/CDK1",3
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/31","30/2914",0.00364529475580855,0.0222854380403677,0.0137303646694209,"MAPK3/JUN/MAPK1",3
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/31","30/2914",0.00364529475580855,0.0222854380403677,0.0137303646694209,"TP53/STAT3/CSNK2A1",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/31","101/2914",0.00375474201840033,0.0222854380403677,0.0137303646694209,"TP53/STAT3/MAPK3/CTNNB1/MAPK1",5
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","4/31","62/2914",0.00380225483153194,0.0222854380403677,0.0137303646694209,"TP53/BRCA1/CDK2/CDK1",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/31","62/2914",0.00380225483153194,0.0222854380403677,0.0137303646694209,"TP53/ABL1/CDK2/CDK5",4
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/31","31/2914",0.00400692591085527,0.0228503072213638,0.0140783883354374,"LEF1/CTNNB1/TCF7",3
"R-HSA-391251","R-HSA-391251","Protein folding","3/31","31/2914",0.00400692591085527,0.0228503072213638,0.0140783883354374,"TP53/STAT3/CSNK2A1",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/31","103/2914",0.00408782040392617,0.0230008028060912,0.0141711107336107,"TP53/STAT3/MAPK3/CTNNB1/MAPK1",5
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/31","32/2914",0.00438974272496665,0.023915756965966,0.0147348265667089,"MAPK3/GSK3B/MAPK1",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/31","10/2914",0.00467486365564173,0.023915756965966,0.0147348265667089,"MAPK3/CDK1",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/31","10/2914",0.00467486365564173,0.023915756965966,0.0147348265667089,"MAPK3/MAPK1",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/31","10/2914",0.00467486365564173,0.023915756965966,0.0147348265667089,"EP300/GSK3B",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/31","10/2914",0.00467486365564173,0.023915756965966,0.0147348265667089,"MAPK3/MAPK1",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/31","10/2914",0.00467486365564173,0.023915756965966,0.0147348265667089,"MAPK3/MAPK1",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","4/31","66/2914",0.00476859408388846,0.023915756965966,0.0147348265667089,"TP53/EP300/CDK2/CDK1",4
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/31","33/2914",0.00479411346287046,0.023915756965966,0.0147348265667089,"MAPK3/MAPK14/MAPK1",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/31","33/2914",0.00479411346287046,0.023915756965966,0.0147348265667089,"MAPK3/CDK1/MAPK1",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/31","107/2914",0.00481715483911637,0.023915756965966,0.0147348265667089,"TP53/EP300/BRCA1/PIAS1/VDR",5
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/31","109/2914",0.00521484578613316,0.0249491378149352,0.0153715067106236,"TP53/EP300/BRCA1/PIAS1/VDR",5
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/31","34/2914",0.00522038906837153,0.0249491378149352,0.0153715067106236,"TP53/ABL1/BRCA1",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/31","34/2914",0.00522038906837153,0.0249491378149352,0.0153715067106236,"TP53/BRCA1/JUN",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","4/31","68/2914",0.005308882470788,0.0249491378149352,0.0153715067106236,"TP53/EP300/CDK2/CDK1",4
"R-HSA-73894","R-HSA-73894","DNA Repair","6/31","157/2914",0.005320906169062,0.0249491378149352,0.0153715067106236,"TP53/EP300/ABL1/BRCA1/CDK2/PIAS1",6
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","5/31","110/2914",0.00542225998405071,0.0251449858601033,0.015492171383002,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","3/31","35/2914",0.00566890353141654,0.0254814620144135,0.0156994789662263,"TP53/ABL1/BRCA1",3
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/31","11/2914",0.00567596547240489,0.0254814620144135,0.0156994789662263,"STAT3/KLF4",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/31","11/2914",0.00567596547240489,0.0254814620144135,0.0156994789662263,"TP53/CDK2",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/31","12/2914",0.00676617673093573,0.0297429852130716,0.0183250619796176,"MAPK3/MAPK1",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/31","12/2914",0.00676617673093573,0.0297429852130716,0.0183250619796176,"MAPK3/MAPK1",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/31","13/2914",0.0079436130867126,0.0335220472259272,0.0206533940254528,"MAPK3/MAPK1",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/31","13/2914",0.0079436130867126,0.0335220472259272,0.0206533940254528,"EP300/BRCA1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/31","13/2914",0.0079436130867126,0.0335220472259272,0.0206533940254528,"TP53/EP300",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/31","13/2914",0.0079436130867126,0.0335220472259272,0.0206533940254528,"BRCA1/CDK2",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","3/31","40/2914",0.00825560661927722,0.0339503694148448,0.0209172892129376,"LEF1/CTNNB1/TCF7",3
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","6/31","172/2914",0.00828646457281757,0.0339503694148448,0.0209172892129376,"TP53/MAPK3/GSK3B/CSNK2A1/JUN/MAPK1",6
"R-HSA-195721","R-HSA-195721","Signaling by WNT","6/31","172/2914",0.00828646457281757,0.0339503694148448,0.0209172892129376,"EP300/GSK3B/CSNK2A1/LEF1/CTNNB1/TCF7",6
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"MAPK3/MAPK1",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"GSK3B/CTNNB1",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"GSK3B/CTNNB1",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"GSK3B/CTNNB1",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"GSK3B/CTNNB1",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"GSK3B/CTNNB1",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"GSK3B/CTNNB1",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/31","14/2914",0.00920641797523625,0.0350009764463937,0.0215645826446975,"TP53/EP300",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","4/31","81/2914",0.009848212019012,0.0370158243834008,0.0228059581509104,"TP53/ABL1/BRCA1/CDK2",4
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","5/31","127/2914",0.00991182027328031,0.0370158243834008,0.0228059581509104,"MAPK3/MAPK14/JUN/MAPK1/DUSP7",5
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/31","43/2914",0.0100923829412094,0.0373595228174593,0.0230177154799512,"MAPK3/ABL1/MAPK1",3
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/31","15/2914",0.0105527622640776,0.0380620997900919,0.0234505828090613,"EP300/GSK3B",2
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","2/31","15/2914",0.0105527622640776,0.0380620997900919,0.0234505828090613,"CDK5/JUN",2
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","2/31","15/2914",0.0105527622640776,0.0380620997900919,0.0234505828090613,"CDK5/JUN",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","5/31","130/2914",0.0109109697526666,0.0390205867425874,0.0240411197940112,"MAPK3/ABL1/MAPK14/CTNNB1/MAPK1",5
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/31","16/2914",0.0119808439088473,0.0410181768000798,0.0252718624834615,"MAPK3/MAPK1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/31","16/2914",0.0119808439088473,0.0410181768000798,0.0252718624834615,"GSK3B/CTNNB1",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/31","16/2914",0.0119808439088473,0.0410181768000798,0.0252718624834615,"TP53/PIAS1",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/31","16/2914",0.0119808439088473,0.0410181768000798,0.0252718624834615,"TP53/CDK1",2
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/31","86/2914",0.0121124679795724,0.0410181768000798,0.0252718624834615,"EP300/ABL1/YAP1/CSNK2A1",4
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/31","46/2914",0.0121499338862796,0.0410181768000798,0.0252718624834615,"NR0B2/VDR/NR2C2AP",3
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/31","46/2914",0.0121499338862796,0.0410181768000798,0.0252718624834615,"TP53/BRCA1/CDK1",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/31","47/2914",0.0128856707690943,0.0428169532642346,0.0263801133855474,"HIF1A/STAT3/CDK2",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/31","47/2914",0.0128856707690943,0.0428169532642346,0.0263801133855474,"HIF1A/STAT3/CDK2",3
"R-HSA-422475","R-HSA-422475","Axon guidance","7/31","254/2914",0.0149557002855639,0.0485626792024449,0.0299201341057718,"MAPK3/ABL1/MAPK14/GSK3B/CSNK2A1/CDK5/MAPK1",7
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/31","18/2914",0.0150751444917542,0.0485626792024449,0.0299201341057718,"CDK2/CDK1",2
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/31","18/2914",0.0150751444917542,0.0485626792024449,0.0299201341057718,"MAPK3/MAPK1",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/31","18/2914",0.0150751444917542,0.0485626792024449,0.0299201341057718,"EP300/CSNK2A1",2
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/31","19/2914",0.0167378917391265,0.053510532681147,0.0329685746376735,"CDK2/CDK1",2
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","6/31","201/2914",0.0171742244643697,0.0544926520598798,0.033573671885234,"TP53/MAPK3/GSK3B/CSNK2A1/JUN/MAPK1",6
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/31","53/2914",0.0178333829671674,0.0561618478518258,0.0346020863542055,"MAPK3/CSNK2A1/MAPK1",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","8/31","332/2914",0.0195122109848202,0.0609937261895859,0.0375790730078018,"TP53/HIF1A/STAT3/MAPK3/MAPK14/JUN/MAPK1/DUSP7",8
"R-HSA-1500620","R-HSA-1500620","Meiosis","2/31","22/2914",0.0221682319431638,0.0673021142447132,0.0414657575915295,"BRCA1/CDK2",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/31","22/2914",0.0221682319431638,0.0673021142447132,0.0414657575915295,"MAPK3/MAPK1",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/31","22/2914",0.0221682319431638,0.0673021142447132,0.0414657575915295,"TP53/CDK2",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/31","22/2914",0.0221682319431638,0.0673021142447132,0.0414657575915295,"TP53/CDK2",2
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","4/31","104/2914",0.0229534593646938,0.0691882846564343,0.04262785310586,"TP53/HIF1A/EP300/JUN",4
"R-HSA-68886","R-HSA-68886","M Phase","4/31","105/2914",0.023686597614336,0.0704596091348546,0.0434111335901948,"MAPK3/CSNK2A1/CDK1/MAPK1",4
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","3/31","59/2914",0.0237091575761833,0.0704596091348546,0.0434111335901948,"ABL1/BRCA1/CDK2",3
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","2/31","23/2914",0.0241202227598992,0.0711799580746675,0.0438549504725439,"ABL1/BRCA1",2
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","8/31","347/2914",0.0249118839181692,0.0730056598157459,0.0449797904078055,"STAT3/MAPK3/MAPK14/YAP1/CDK5/CTNNB1/MAPK1/DUSP7",8
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","4/31","108/2914",0.0259721229324683,0.0735418548275753,0.0453101475240985,"EP300/MAPK3/JUN/MAPK1",4
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/31","24/2914",0.0261404697254414,0.0735418548275753,0.0453101475240985,"HIF1A/EP300",2
"R-HSA-1474165","R-HSA-1474165","Reproduction","2/31","24/2914",0.0261404697254414,0.0735418548275753,0.0453101475240985,"BRCA1/CDK2",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/31","24/2914",0.0261404697254414,0.0735418548275753,0.0453101475240985,"TP53/CDK2",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/31","24/2914",0.0261404697254414,0.0735418548275753,0.0453101475240985,"TP53/CDK2",2
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/31","24/2914",0.0261404697254414,0.0735418548275753,0.0453101475240985,"MAPK3/MAPK1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/31","62/2914",0.0269981850355001,0.0754518813574905,0.0464869411207287,"MAPK3/ABL1/MAPK1",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","3/31","63/2914",0.0281465950441959,0.0778559652782827,0.0479681302662405,"ABL1/BRCA1/CDK2",3
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/31","25/2914",0.0282273997335954,0.0778559652782827,0.0479681302662405,"MAPK3/MAPK1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/31","114/2914",0.0309359752499688,0.0847726075031613,0.0522295686038435,"TP53/BRCA1/CDK2/CDK1",4
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/31","27/2914",0.03259513542273,0.0865103594238494,0.0533002214459735,"EP300/JUN",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/31","27/2914",0.03259513542273,0.0865103594238494,0.0533002214459735,"EP300/JUN",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/31","27/2914",0.03259513542273,0.0865103594238494,0.0533002214459735,"MAPK3/MAPK1",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/31","27/2914",0.03259513542273,0.0865103594238494,0.0533002214459735,"TP53/CDK1",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/31","27/2914",0.03259513542273,0.0865103594238494,0.0533002214459735,"ABL1/YAP1",2
"R-HSA-109582","R-HSA-109582","Hemostasis","7/31","298/2914",0.0332190474483887,0.0876152376451252,0.0539809521036316,"TP53/MAPK3/ABL1/MAPK14/CDK2/CDK5/MAPK1",7
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/31","28/2914",0.0348729129540618,0.0908417855963832,0.0559688726423214,"PIAS1/VDR",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/31","28/2914",0.0348729129540618,0.0908417855963832,0.0559688726423214,"MAPK3/MAPK1",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/31","30/2914",0.0396088896232131,0.101920435493878,0.062794581109972,"GSK3B/CTNNB1",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/31","30/2914",0.0396088896232131,0.101920435493878,0.062794581109972,"MAPK3/MAPK1",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/31","31/2914",0.0420641974654447,0.107582371699501,0.066282977824337,"GSK3B/CTNNB1",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/31","32/2914",0.0445758277814766,0.111970234070138,0.0689864001379994,"MAPK3/MAPK1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/31","32/2914",0.0445758277814766,0.111970234070138,0.0689864001379994,"MAPK3/MAPK1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/31","32/2914",0.0445758277814766,0.111970234070138,0.0689864001379994,"MAPK3/MAPK1",2
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","3/31","76/2914",0.0454235846353652,0.113424572284758,0.0698824379005619,"LEF1/CTNNB1/TCF7",3
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/31","77/2914",0.0469305512204661,0.116498191853157,0.0717761371607129,"ABL1/CDK2/CDK1",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","8/31","393/2914",0.0480858526266842,0.118668010575794,0.0731129922978824,"TP53/HIF1A/EP300/BRCA1/SMAD1/CDK1/PIAS1/VDR",8
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/31","34/2914",0.0497625150535307,0.119998750586228,0.0739328795081028,"CDK2/CDK1",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/31","34/2914",0.0497625150535307,0.119998750586228,0.0739328795081028,"EP300/CTNNB1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/31","34/2914",0.0497625150535307,0.119998750586228,0.0739328795081028,"MAPK3/MAPK1",2
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","2/31","34/2914",0.0497625150535307,0.119998750586228,0.0739328795081028,"CDK1/JUN",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/31","80/2914",0.0516004388863547,0.12372377960251,0.0762279210821148,"TP53/HIF1A/SMAD1",3
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","4/31","136/2914",0.0537354200414934,0.12811495625712,0.0789333853716853,"EP300/MAPK3/JUN/MAPK1",4
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/31","37/2914",0.057930893779616,0.135815762083322,0.0836779576816676,"EP300/GSK3B",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/31","37/2914",0.057930893779616,0.135815762083322,0.0836779576816676,"EP300/PIAS1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/31","37/2914",0.057930893779616,0.135815762083322,0.0836779576816676,"MAPK3/MAPK1",2
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","6/31","268/2914",0.0592212752950582,0.138073912566379,0.0850692352304703,"STAT3/EP300/MAPK3/GSK3B/CTNNB1/MAPK1",6
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/31","38/2914",0.0607520004783365,0.139333392401402,0.0858452180672147,"BRCA1/PIAS1",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/31","38/2914",0.0607520004783365,0.139333392401402,0.0858452180672147,"GSK3B/CDK5",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/31","38/2914",0.0607520004783365,0.139333392401402,0.0858452180672147,"MAPK3/MAPK1",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/31","87/2914",0.0633481391277478,0.144502241685998,0.0890298171525103,"MAPK3/JUN/MAPK1",3
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/31","40/2914",0.0665340606978438,0.148557532351799,0.0915283374679333,"CDK2/CDK1",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/31","40/2914",0.0665340606978438,0.148557532351799,0.0915283374679333,"HIF1A/EP300",2
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/31","40/2914",0.0665340606978438,0.148557532351799,0.0915283374679333,"EP300/KLF4",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/31","40/2914",0.0665340606978438,0.148557532351799,0.0915283374679333,"CDK2/CDK1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/31","41/2914",0.069492542610902,0.154346594641056,0.0950950583096554,"MAPK3/MAPK1",2
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/31","42/2914",0.0724943771478864,0.156885267468759,0.0966591695305152,"CTNNB1/KLF4",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/31","42/2914",0.0724943771478864,0.156885267468759,0.0966591695305152,"MAPK3/MAPK1",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/31","42/2914",0.0724943771478864,0.156885267468759,0.0966591695305152,"MAPK3/MAPK1",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/31","42/2914",0.0724943771478864,0.156885267468759,0.0966591695305152,"MAPK3/MAPK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/31","42/2914",0.0724943771478864,0.156885267468759,0.0966591695305152,"MAPK3/MAPK1",2
"R-HSA-168249","R-HSA-168249","Innate Immune System","8/31","428/2914",0.0733564661272773,0.15794096278424,0.0973095979239392,"EP300/MAPK3/ABL1/MAPK14/CTNNB1/JUN/MAPK1/DUSP7",8
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","3/31","94/2914",0.0762433030039644,0.163323217602401,0.100625679091527,"TP53/HIF1A/STAT3",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/31","46/2914",0.0849117745729255,0.180973580150377,0.111500310045256,"MAPK3/MAPK1",2
"R-HSA-1643685","R-HSA-1643685","Disease","8/31","443/2914",0.0863818335858736,0.183181576749943,0.112860687097121,"STAT3/EP300/MAPK3/GSK3B/CDK5/CTNNB1/JUN/MAPK1",8
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/31","47/2914",0.0881129347419847,0.185918292305588,0.11454681516458,"MAPK3/MAPK1",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","5/31","228/2914",0.0896820275699033,0.188287639972633,0.116006602826741,"MAPK3/ABL1/MAPK14/CTNNB1/MAPK1",5
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","2/31","48/2914",0.0913506013705628,0.190841355338502,0.117579981962111,"BRCA1/CDK2",2
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/31","49/2914",0.0946236967278197,0.193840776791941,0.11942796674385,"MAPK3/MAPK1",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/31","49/2914",0.0946236967278197,0.193840776791941,0.11942796674385,"MAPK3/MAPK1",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/31","49/2914",0.0946236967278197,0.193840776791941,0.11942796674385,"EP300/JUN",2
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","2/31","49/2914",0.0946236967278197,0.193840776791941,0.11942796674385,"EP300/KLF4",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/31","50/2914",0.0979311605383627,0.199647100227966,0.123005322415335,"MAPK3/MAPK1",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"BRCA1",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"CDK1",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"TP53",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/31","10/2914",0.101581519518315,0.200314959050135,0.123416799414775,"EP300",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","2/31","52/2914",0.104645038318719,0.203503254241932,0.125381151902612,"HIF1A/EP300",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/31","52/2914",0.104645038318719,0.203503254241932,0.125381151902612,"MAPK3/MAPK1",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/31","52/2914",0.104645038318719,0.203503254241932,0.125381151902612,"MAPK3/MAPK1",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"STAT3",1
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"CDK1",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"EP300",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"TP53",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"TP53",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"CDK1",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"GSK3B",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/31","11/2914",0.111172074922906,0.206672315495446,0.12733365409672,"STAT3",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/31","55/2914",0.114948089899448,0.211825737718633,0.130508748357452,"MAPK3/MAPK1",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/31","55/2914",0.114948089899448,0.211825737718633,0.130508748357452,"EP300/PIAS1",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/31","56/2914",0.118440447529224,0.213949603066899,0.131817290989085,"CSNK2A1/CDK1",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"CSNK2A1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"STAT3",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"YAP1",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"EP300",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"CDK1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"CTNNB1",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/31","12/2914",0.120663520213085,0.213949603066899,0.131817290989085,"CDK2",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/31","59/2914",0.129078319006963,0.21866131048021,0.13472023868449,"CDK5/MAPK1",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"EP300",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"MAPK14",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"GSK3B",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"CTNNB1",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"EP300",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/31","13/2914",0.13005684580695,0.21866131048021,0.13472023868449,"EP300",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/31","119/2914",0.130643643092062,0.21877625946369,0.134791060333079,"EP300/CSNK2A1/VDR",3
"R-HSA-69206","R-HSA-69206","G1/S Transition","2/31","60/2914",0.132674831479979,0.221299521282812,0.136345676619742,"CDK2/CDK1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/31","14/2914",0.139353032563235,0.227053975836622,0.139891075160004,"CTNNB1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/31","14/2914",0.139353032563235,0.227053975836622,0.139891075160004,"BRCA1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/31","14/2914",0.139353032563235,0.227053975836622,0.139891075160004,"PIAS1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/31","14/2914",0.139353032563235,0.227053975836622,0.139891075160004,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/31","14/2914",0.139353032563235,0.227053975836622,0.139891075160004,"EP300",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/31","14/2914",0.139353032563235,0.227053975836622,0.139891075160004,"KLF4",1
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/31","63/2914",0.143603673414197,0.231326154572967,0.142523223196615,"MAPK3/MAPK1",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/31","64/2914",0.147290210963672,0.231326154572967,0.142523223196615,"HIF1A/EP300",2
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"CDK1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"YAP1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"MAPK14",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"BRCA1",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"TP53",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"CDK1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"TP53",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"CTNNB1",1
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","1/31","15/2914",0.148553051870318,0.231326154572967,0.142523223196615,"STAT3",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/31","16/2914",0.157657865734416,0.242816128977822,0.149602354346526,"CDK2",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/31","16/2914",0.157657865734416,0.242816128977822,0.149602354346526,"CSNK2A1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/31","16/2914",0.157657865734416,0.242816128977822,0.149602354346526,"EP300",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/31","17/2914",0.166668426867002,0.252093462859766,0.155318247259571,"CDK1",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/31","17/2914",0.166668426867002,0.252093462859766,0.155318247259571,"PIAS1",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/31","17/2914",0.166668426867002,0.252093462859766,0.155318247259571,"MAPK14",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/31","17/2914",0.166668426867002,0.252093462859766,0.155318247259571,"CDK2",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/31","17/2914",0.166668426867002,0.252093462859766,0.155318247259571,"EP300",1
"R-HSA-69242","R-HSA-69242","S Phase","2/31","71/2914",0.173622997858303,0.260905480427966,0.160747452396377,"GSK3B/CDK2",2
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/31","18/2914",0.175585678771428,0.260905480427966,0.160747452396377,"HIF1A",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/31","18/2914",0.175585678771428,0.260905480427966,0.160747452396377,"GSK3B",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/31","18/2914",0.175585678771428,0.260905480427966,0.160747452396377,"BRCA1",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/31","18/2914",0.175585678771428,0.260905480427966,0.160747452396377,"EP300",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"CDK1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"CTNNB1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"GSK3B",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"EP300",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"CSNK2A1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/31","19/2914",0.184410555828777,0.267426991614241,0.164765445070385,"EP300",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/31","20/2914",0.193143983382943,0.275360679012169,0.16965349891745,"MAPK14",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/31","20/2914",0.193143983382943,0.275360679012169,0.16965349891745,"MAPK1",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/31","20/2914",0.193143983382943,0.275360679012169,0.16965349891745,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/31","20/2914",0.193143983382943,0.275360679012169,0.16965349891745,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/31","20/2914",0.193143983382943,0.275360679012169,0.16965349891745,"EP300",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/31","77/2914",0.196790929883106,0.279615395322123,0.172274888113157,"MAPK3/MAPK1",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/31","21/2914",0.201786877824936,0.284796195458606,0.175466850282553,"CTNNB1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/31","21/2914",0.201786877824936,0.284796195458606,0.175466850282553,"MAPK14",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","2/31","80/2914",0.208531222629125,0.291985335189018,0.179896178078542,"MAPK14/CDK1",2
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/31","22/2914",0.210340146676449,0.291985335189018,0.179896178078542,"STAT3",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/31","22/2914",0.210340146676449,0.291985335189018,0.179896178078542,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/31","22/2914",0.210340146676449,0.291985335189018,0.179896178078542,"CDK2",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/31","22/2914",0.210340146676449,0.291985335189018,0.179896178078542,"EP300",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/31","23/2914",0.218804688672656,0.297856705225357,0.183513609854486,"SMAD1",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/31","23/2914",0.218804688672656,0.297856705225357,0.183513609854486,"MAPK14",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/31","23/2914",0.218804688672656,0.297856705225357,0.183513609854486,"PIAS1",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/31","23/2914",0.218804688672656,0.297856705225357,0.183513609854486,"BRCA1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/31","23/2914",0.218804688672656,0.297856705225357,0.183513609854486,"STAT3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/31","23/2914",0.218804688672656,0.297856705225357,0.183513609854486,"CDK2",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/31","153/2914",0.220482406369232,0.299175483883653,0.184326127511255,"MAPK3/MAPK14/MAPK1",3
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/31","24/2914",0.227181393844273,0.30338781076672,0.186921399998453,"STAT3",1
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","1/31","24/2914",0.227181393844273,0.30338781076672,0.186921399998453,"EP300",1
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","1/31","24/2914",0.227181393844273,0.30338781076672,0.186921399998453,"GSK3B",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/31","24/2914",0.227181393844273,0.30338781076672,0.186921399998453,"BRCA1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/31","24/2914",0.227181393844273,0.30338781076672,0.186921399998453,"STAT3",1
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","2/31","85/2914",0.228270652459578,0.303880805482466,0.187225140818581,"MAPK14/CTNNB1",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/31","25/2914",0.235471143598885,0.307643413618358,0.189543335404675,"CDK1",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/31","25/2914",0.235471143598885,0.307643413618358,0.189543335404675,"CDK1",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/31","25/2914",0.235471143598885,0.307643413618358,0.189543335404675,"CTNNB1",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/31","25/2914",0.235471143598885,0.307643413618358,0.189543335404675,"EP300",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/31","25/2914",0.235471143598885,0.307643413618358,0.189543335404675,"CSNK2A1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/31","25/2914",0.235471143598885,0.307643413618358,0.189543335404675,"CDK5",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/31","88/2914",0.24019181828659,0.312555532395881,0.19256975929604,"MAPK3/MAPK1",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/31","26/2914",0.243674810801528,0.312555532395881,0.19256975929604,"MAPK1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/31","26/2914",0.243674810801528,0.312555532395881,0.19256975929604,"CDK1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/31","26/2914",0.243674810801528,0.312555532395881,0.19256975929604,"CTNNB1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/31","26/2914",0.243674810801528,0.312555532395881,0.19256975929604,"CDK1",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/31","26/2914",0.243674810801528,0.312555532395881,0.19256975929604,"GSK3B",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/31","27/2914",0.251793259854559,0.317184345249623,0.195421634513986,"YAP1",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/31","27/2914",0.251793259854559,0.317184345249623,0.195421634513986,"CDK1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/31","27/2914",0.251793259854559,0.317184345249623,0.195421634513986,"CDK1",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/31","27/2914",0.251793259854559,0.317184345249623,0.195421634513986,"CDK1",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/31","27/2914",0.251793259854559,0.317184345249623,0.195421634513986,"BRCA1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/31","27/2914",0.251793259854559,0.317184345249623,0.195421634513986,"CDK2",1
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","2/31","92/2914",0.256146454210868,0.320605673508215,0.197529561877099,"MAPK14/CTNNB1",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","2/31","92/2914",0.256146454210868,0.320605673508215,0.197529561877099,"MAPK3/MAPK1",2
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/31","28/2914",0.2598273467768,0.320605673508215,0.197529561877099,"CDK1",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/31","28/2914",0.2598273467768,0.320605673508215,0.197529561877099,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/31","28/2914",0.2598273467768,0.320605673508215,0.197529561877099,"EP300",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/31","28/2914",0.2598273467768,0.320605673508215,0.197529561877099,"VDR",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/31","28/2914",0.2598273467768,0.320605673508215,0.197529561877099,"EP300",1
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","1/31","29/2914",0.267777919281968,0.326596190569337,0.201220401772577,"TP53",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/31","29/2914",0.267777919281968,0.326596190569337,0.201220401772577,"CDK1",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/31","29/2914",0.267777919281968,0.326596190569337,0.201220401772577,"STAT3",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/31","29/2914",0.267777919281968,0.326596190569337,0.201220401772577,"EP300",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/31","30/2914",0.275645816856409,0.331997752219607,0.204548378144781,"CSNK2A1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/31","30/2914",0.275645816856409,0.331997752219607,0.204548378144781,"CDK1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/31","30/2914",0.275645816856409,0.331997752219607,0.204548378144781,"TP53",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/31","30/2914",0.275645816856409,0.331997752219607,0.204548378144781,"PIAS1",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/31","97/2914",0.276140310495455,0.331997752219607,0.204548378144781,"MAPK3/PIAS1",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/31","31/2914",0.283431870836107,0.338722320307695,0.208691476966826,"MAPK14",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/31","31/2914",0.283431870836107,0.338722320307695,0.208691476966826,"STAT3",1
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","2/31","99/2914",0.284141472485602,0.338722320307695,0.208691476966826,"MAPK3/MAPK1",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/31","32/2914",0.291136904483031,0.345111723853481,0.212628076307832,"STAT3",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/31","32/2914",0.291136904483031,0.345111723853481,0.212628076307832,"EP300",1
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/31","33/2914",0.298761733060764,0.350215142643451,0.215772362766108,"MAPK14",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/31","33/2914",0.298761733060764,0.350215142643451,0.215772362766108,"BRCA1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/31","33/2914",0.298761733060764,0.350215142643451,0.215772362766108,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/31","33/2914",0.298761733060764,0.350215142643451,0.215772362766108,"CDK2",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/31","34/2914",0.306307163909468,0.354141433341905,0.218191404428662,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/31","34/2914",0.306307163909468,0.354141433341905,0.218191404428662,"MAPK1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/31","34/2914",0.306307163909468,0.354141433341905,0.218191404428662,"MAPK3",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/31","34/2914",0.306307163909468,0.354141433341905,0.218191404428662,"CDK1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/31","34/2914",0.306307163909468,0.354141433341905,0.218191404428662,"EP300",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/31","105/2914",0.308112265914895,0.355255126273458,0.218877565950472,"MAPK3/MAPK1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/31","35/2914",0.313773996520165,0.356907349141535,0.219895523167771,"MAPK3",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/31","35/2914",0.313773996520165,0.356907349141535,0.219895523167771,"MAPK14",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/31","35/2914",0.313773996520165,0.356907349141535,0.219895523167771,"CTNNB1",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/31","35/2914",0.313773996520165,0.356907349141535,0.219895523167771,"GSK3B",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/31","35/2914",0.313773996520165,0.356907349141535,0.219895523167771,"TP53",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/31","37/2914",0.328475026186922,0.3716259009407,0.228963825224128,"CDK1",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/31","37/2914",0.328475026186922,0.3716259009407,0.228963825224128,"EP300",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/31","38/2914",0.335710783638505,0.378796659613501,0.233381828197891,"MAPK14",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/31","39/2914",0.342871063787047,0.384818055633335,0.237091693044235,"EP300",1
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","1/31","39/2914",0.342871063787047,0.384818055633335,0.237091693044235,"CDK2",1
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","1/31","40/2914",0.349956627968822,0.388636044744323,0.239444008610246,"ABL1",1
"R-HSA-69236","R-HSA-69236","G1 Phase","1/31","40/2914",0.349956627968822,0.388636044744323,0.239444008610246,"ABL1",1
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","1/31","40/2914",0.349956627968822,0.388636044744323,0.239444008610246,"CDK2",1
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","1/31","40/2914",0.349956627968822,0.388636044744323,0.239444008610246,"EP300",1
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/31","41/2914",0.35696823010277,0.39434710236484,0.242962669703456,"STAT3",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/31","41/2914",0.35696823010277,0.39434710236484,0.242962669703456,"STAT3",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/31","42/2914",0.363906616760206,0.398879460448849,0.245755117812087,"MAPK14",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/31","42/2914",0.363906616760206,0.398879460448849,0.245755117812087,"CDK1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/31","42/2914",0.363906616760206,0.398879460448849,0.245755117812087,"STAT3",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/31","44/2914",0.3775666936065,0.411713552201403,0.253662378133566,"YAP1",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/31","44/2914",0.3775666936065,0.411713552201403,0.253662378133566,"CDK2",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/31","45/2914",0.384289840818416,0.41796472377673,0.257513810857701,"STAT3",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/31","125/2914",0.386770068470526,0.419580896901187,0.258509557332485,"MAPK14/MAPK1",2
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/31","46/2914",0.390942686734982,0.42302003539016,0.260628457823321,"PIAS1",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/31","47/2914",0.39752594221309,0.427948845953888,0.26366516575358,"EP300",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/31","47/2914",0.39752594221309,0.427948845953888,0.26366516575358,"PIAS1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/31","48/2914",0.404040311167187,0.432753835818662,0.266625586049413,"MAPK14",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/31","48/2914",0.404040311167187,0.432753835818662,0.266625586049413,"EP300",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/31","49/2914",0.410486490634674,0.438545060880588,0.270193639405102,"STAT3",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"EP300",1
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"EP300",1
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"EP300",1
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"EP300",1
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"EP300",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"CDK2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/31","51/2914",0.423177035262487,0.444230619106392,0.273696589970763,"HIF1A",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/31","53/2914",0.435603017303003,0.456140132262698,0.281034204711615,"CSNK2A1",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","1/31","55/2914",0.447769772017101,0.467719910374299,0.288168665159521,"GSK3B",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/31","57/2914",0.459682530710645,0.478977846814548,0.29510483453029,"CTNNB1",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/31","61/2914",0.482766477176233,0.501791757064952,0.309160798191677,"CSNK2A1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/31","62/2914",0.488386610091598,0.506386116606031,0.311991446250161,"STAT3",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/31","64/2914",0.499450123837959,0.51658811828338,0.31827703970066,"ABL1",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/31","66/2914",0.510281947579214,0.526501178186866,0.324384612153046,"EP300",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/31","165/2914",0.53159067438983,0.547149425835386,0.33710628132038,"MAPK3/MAPK1",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/31","72/2914",0.541433756726109,0.555924684521698,0.342512838804838,"EP300",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","1/31","82/2914",0.589140062550841,0.603439578632172,0.371787418114609,"STAT3",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","3/31","289/2914",0.606774022054267,0.618572174837158,0.38111081862005,"EP300/CSNK2A1/VDR",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","1/31","86/2914",0.606845688110388,0.618572174837158,0.38111081862005,"SMAD1",1
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","1/31","97/2914",0.651812745141669,0.662807176987432,0.408364611414058,"GSK3B",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/31","217/2914",0.684249494603705,0.694118477698951,0.427655934127316,"CDK5/MAPK1",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/31","109/2914",0.695189080697879,0.700166568149177,0.431382245779114,"EP300",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/31","109/2914",0.695189080697879,0.700166568149177,0.431382245779114,"EP300",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/31","109/2914",0.695189080697879,0.700166568149177,0.431382245779114,"MAPK14",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/31","126/2914",0.747799858836135,0.751360810544879,0.462923722136655,"CTNNB1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","3/31","436/2914",0.86427377822985,0.8663266850665,0.533755777529123,"MAPK3/CDK5/MAPK1",3
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","3/31","486/2914",0.91085627372368,0.91085627372368,0.561191069118855,"MAPK3/CDK5/MAPK1",3
